Protein C News and Research

RSS

SARS-CoV-2 genome analysis reveals new 'Mexican variant'

A research group of the Department of Pharmacy and Biotechnology of the University of Bologna analyzed more than one million SARS-CoV-2 genome sequences.

5 Jun 2021

New bioengineered reporter system allows to follow protein isoform expression over time in live cells

Our proteome is much bigger than our genome because one gene produces several variants of proteins called protein isoforms, whose disbalance is implicated in many diseases. c

5 Jun 2021

Study finds molecular pathway that can explain how chronic kidney disease induces heart failure

According to the Global Burden of Disease Study 2017, close to nine percent of the global population lives with some form of chronic kidney disease, or CKD. Not only does the condition affect renal function, CKD has long been associated with increased risk of cardiovascular disease.

5 Jun 2021

New treatment option offers disease control and extends life in patients with advanced prostate cancer

Cancer researchers say they have established a new, life-extending treatment option for men with prostate cancer that has spread and become resistant to hormone therapy.

5 Jun 2021

Georgia State professor receives federal grant to study seasonal and universal vaccination in elderly populations

Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.7 million federal grant to study seasonal and universal vaccination in elderly populations with pre-existing immunity to influenza viruses.

5 Jun 2021

Increasing a protein concentrated in brown fat may lower diabetes risk

Increasing a protein concentrated in brown fat appears to lower blood sugar, promote insulin sensitivity, and protect against fatty liver disease by remodeling white fat to a healthier state, a new study led by UT Southwestern scientists suggests.

5 Jun 2021

FDA approves new treatment for patients with hypoplasminogenemia

Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a disorder that can impair normal tissue and organ function and may lead to blindness.

5 Jun 2021

Maternal SARS-CoV-2 infection imprints immune response in the newborn

A new bioRxiv* preprint reports the immunological footprint in the newborn left by maternal infection with SARS-CoV-2 during pregnancy.

4 Jun 2021

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

In a new study by researchers in the UK, Germany and South Africa, this process is visualized using time-lapse microscopy of a human cell lung line, demonstrating that SARS-CoV-2 can induce cell-to-cell fusion within 6 hours post-infection. Further, the application of neutralizing monoclonal antibodies or convalescent plasma was unable to prevent the spread of the virus by this mechanism, suggesting that removing SARS-CoV-2 from cells permissive of cell membrane fusion could be more difficult than other types of cell.

4 Jun 2021

How mass screening efforts have helped identify more cases of celiac disease in children

A new mass screening program of school-aged children in Italy found that the overall prevalence of celiac disease has almost doubled in the past 25 years.

4 Jun 2021

Waters launches new RUO LC-MS test method to advance infectious disease research

Waters Corporation today introduced a new RUO LC-MS test method to advance critical infectious disease research.

4 Jun 2021

Study brings to light the role of a cellular protein in COVID-19 infections

Angiotensin-converting enzyme 2 (ACE2), a protein found on the surface of lung cells, facilitates the entry of the novel coronavirus into host cells.

4 Jun 2021

Study identifies new genetic variants that cause developmental disorders in children

Non-coding regions of DNA could hold the key to diagnosing developmental disorders in children, new research suggests.

4 Jun 2021

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

Vaccination efforts against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease (COVID-19) pandemic, are well underway in many countries. Over 2 billion vaccines have been administered to date, and campaigns continue to encourage more people to get vaccinated.

4 Jun 2021

New strategy for developing universal flu vaccine

A new study from the University of Chicago and Scripps Research Institute shows that during the last great pandemic--2009's H1N1 influenza pandemic--people developed strong, effective immune responses to stable, conserved parts of the virus.

4 Jun 2021

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

A preprint paper uploaded to the bioRxiv* server shows how combining drugs targeting different entry factors of the host cell may prevent infection by the virus.

3 Jun 2021

Mast cell activation may underlie inflammation in severe COVID-19

A new preprint research paper posted to the medRxiv* server points to mast cells as major culprits in the etiology of severe and critical COVID-19. This could suggest suitable therapeutic and preventive interventions to reduce the morbidity and mortality of this viral illness.

3 Jun 2021

Protein C News and Research

SARS-CoV-2 genome analysis reveals new 'Mexican variant'

New bioengineered reporter system allows to follow protein isoform expression over time in live cells

Study finds molecular pathway that can explain how chronic kidney disease induces heart failure

New treatment option offers disease control and extends life in patients with advanced prostate cancer

Georgia State professor receives federal grant to study seasonal and universal vaccination in elderly populations

Increasing a protein concentrated in brown fat may lower diabetes risk

FDA approves new treatment for patients with hypoplasminogenemia

Maternal SARS-CoV-2 infection imprints immune response in the newborn

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

How mass screening efforts have helped identify more cases of celiac disease in children

Waters launches new RUO LC-MS test method to advance infectious disease research

Study brings to light the role of a cellular protein in COVID-19 infections

Study identifies new genetic variants that cause developmental disorders in children

Clinical trial evaluating mixed COVID-19 vaccine schedules begins at NIH

New strategy for developing universal flu vaccine

Two repurposed drugs inhibit SARS-CoV-2 entry factors in a synergistic manner

Mast cell activation may underlie inflammation in severe COVID-19

Lung protein hyperconcentration may be a key factor in predicting COPD risks

New therapeutic approach developed to treat psoriatic arthritis

How can nanomaterials help in the fight against COVID-19?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News